Søgning på udtrykket 'covid-19' giver 82 resultater
Dokumenter [9] Sider [3] Kalender [29] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [9]
Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.
Invitation til møde den 20. maj 2022
Ændringer siden sidste udgave: 1. Simplificering af risikogrupper. 2. Skærpelse af kriterier for opstart af behandling hos indlagte patienter, f.eks. blodgas analyse før remdesivir. 3. Information om høj pris på paxlovid og højere NNT for beskyttelse mod alvorligt forløb siden primærpublikation.
COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed
Virtuelt årsmøde med fokus på COVID-19 den 7. maj 2021
DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.
Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale
Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.
Afholdt fredag den 25. september 2020 som onlinemøde med fokus på COVID-19
Sider [3]
… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Behandling af COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2024v28), Post-COVID-19: Jacob Bodilsen, Christian Brandt, Stine Jo…
…diagnostiske undersøgelser ikke forsinke empirisk behandling ved symptomer herpå. Vaccinationer: Primær vaccination foretages mod Streptococcus pneumoniae, Haemophilus influenzae type B og Neisseria meningitidis. Årlig influenza-vaccination (samt COVID-19 vaccination ud fra aktuelle rekommandationer) anbefales på grund af øget risiko for sekundær bakteriel infektion. Pneumokokker. Den 20-valent konjugerede pneumokok vaccine, PCV20 (Apexxnar), anbefales til voksne. Apexxnar er en…
Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid. Alle infektionsmedicinere bør kende denne publikat…
Kalender [29]
16. januar 2023, Online
14. december 2022, Online
11. oktober 2022, Online
20. maj 2022, Aarhus Universitet
21. marts 2022, Aarhus Universitetshospital, Skejby
9. februar 2022, Online
4. januar 2022, Online
7. december 2021, Online
4. november 2021, Online
23. september 2021, Aarhus
21. september 2021, Online
31. august 2021, Holst Auditoriet, Mærsk Tårnet, København
16. juni 2021, Online
27. maj 2021, Online
7. maj 2021, Online
13. april 2021, Online
23. marts 2021, Online
22. marts 2021, Online
16. marts 2021, Online
3. februar 2021, Online
28. januar 2021, Online
19. januar 2021, Online
30. december 2020, Online
9. oktober 2020, Århus og online
25. september 2020, Online
28. juni 2020, Online
18. juni 2020, Aflyst på grund af COVID-19
3. juni 2020, Mødet udskudt på grund af COVID-19
24. marts 2020, København
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Moral distress related to paid and unpaid care among healthcare workers during the COVID-19 pandemic
PLoS One Infectious Diseases
10.09.2024
by Julia Smith, Muhammad Haaris Tiwana, Alice Murage, Hasina Samji, Rosemary Morgan, Jorge Andres Delgado-Ron . While there is growing literature on experiences of healthcare workers and those providing unpaid care during COVID-19, little research considers the relationships between paid and unpaid care burdens and contributions. We administered a moral distress survey to healthcare workers in Canada, in 2022, collecting data on both paid and unpaid care. There were no significant differences in the propor…
BMC Infectious Diseases
10.09.2024
. Abstract. . Background. The mortality risk of co-infections/secondary infections (CoI/ScI) is under-reported in patients with non-critical COVID-19, leading to the under-management of CoI/ScI and publication bias in the medical literature. We aimed to investigate the association between CoI/ScI and mortality in patients hospitalised with mild-to-severe COVID-19. . . . …
BMC Infectious Diseases
10.09.2024
. Abstract. . Background. While COVID-19 has been controlled and deaths have decreased, the long-term consequences of COVID-19 remain a challenge we face today. This study was conducted to determine the relationship between the apoptosis of lymphocyte cells with DNA damage and oxidative stress and the therapeutic and clinical outcomes of elderly patients with COVID-19. . . . …
BMC Infectious Diseases
10.09.2024
. Abstract. . Background. Pregnancy is a critical time for women, making them more susceptible to infectious diseases like COVID-19. This study aims to determine the immunogenicity of COVID-19 in pregnant women who have been infected compared to those who have received the inactive COVID-19 vaccine. . . . Materials and methods. In this retro…
Lancet Infectious Diseases
10.09.2024
In a vaccinated population, people treated with molnupiravir for acute COVID-19 felt better, experienced fewer and less severe COVID-19 associated symptoms, accessed health care less often, and took less time off work at 6 months. However, the absolute differences in this open-label design are small with high numbers needed to treat.
BMC Infectious Diseases
7.09.2024
. Abstract. . Background. Self-medication practices involve the use of medications without healthcare professional requests. The threat of coronavirus disease 2019 (COVID-19) caused the practice of a fittest to survive action, with the assumption that something is better than nothing. Moreover, owing to the lack of effective treatment for COVID-19, the general public has shifted toward self-medication and symptomatic treatme…
PLoS One Infectious Diseases
7.09.2024
by The PLOS ONE Editors .
International Journal of Infectious Diseases
6.09.2024
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection caused global pandemic of COVID-19 disease with nearly 775 million cases and 7 million cumulative deaths worldwide. The Czech Republic was among countries most affected [1], with more than 4.5 mil confirmed cumulative cases and almost 43,500 deaths. (//covid19.who.int, accessed March 07, 2024).
Journal of Infectious Diseases
6.09.2024
Abstract . Coronavirus disease 2019 (COVID-19) vaccines reduce severe disease and mortality and may lessen transmission, measured by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load (VL). Evaluating vaccine associations in VL at COVID-19 diagnosis in 4 phase 3 randomized, placebo-controlled vaccine trials, July 2020 to July 2021, VL reductions were 2.78 log10 copies/mL (95% confidence interval [CI], 1.38–4.18; n = 60 placebo, 11 vaccine) and 2.12 log10 copies/mL (95% CI, 1.44–2.80…
BMC Infectious Diseases
5.09.2024
…g real-world data. . . . Methods. We analyzed the electronic medical records of adult patients admitted to Busan Medical Center after confirming coronavirus disease 2019 (COVID-19) from February 1, 2020, to June 30, 2022. Patients with mild-to-moderate COVID-19 who were at a high risk of disease progression were selected as study subjects, and the time period was classified according to the variants as ancestral strain, Del…
BMC Infectious Diseases
5.09.2024
. Abstract. . Background. To mitigate hospital-acquired transmission of coronavirus disease 2019 (COVID-19), various prevention and control measures have been strictly implemented in medical institutions. These stringent measures can potentially reduce the incidence of hospital-acquired respiratory infections. This study aimed to assess if there were changes in the prevalence of hospital-acquired respiratory infections durin…
BMC Infectious Diseases
5.09.2024
. Abstract. . Background. After a 920-day hiatus, COVID-19 resurged in the Tibet Autonomous Region of China in August 2022. This study compares the characteristics of COVID-19 between high-altitude residents and newcomers, as well as between newcomers and lowlanders. . . . Methods. This multi-center cohort study conducted at the Third People…
PLoS One Infectious Diseases
5.09.2024
by Qian Wang, You Zhou, Gang Wang, Xinyu Pan, Sha Sha, Zhe Wang, Yinqi Liu, Tengfei Tian, Sixiang Liang . Background In context of COVID-19 as a collective trauma and the intense involvement of healthcare workers (HCWs) in the pandemic, perceived stress continues to have a tremendous impact on their psychological well-being. However, few studies have attempted to delineate the underlying mechanisms. This study examined whether COVID-19-related traumatic stress symptoms and mentalization act as mediators. …
PLoS One Infectious Diseases
4.09.2024
by Kenny Nguyen, Boris Relja, Monica Epperson, So Hee Park, Natalie J. Thornburg, Veronica P. Costantini, Jan Vinjé . mRNA-based COVID-19 vaccines have played a critical role in reducing severe outcomes of COVID-19. Humoral immune responses against SARS-CoV-2 after vaccination have been extensively studied in blood; however, limited information is available on the presence and duration of SARS-CoV-2 specific antibodies in saliva and other mucosal fluids. Saliva offers a non-invasive sampling method that m…
International Journal of Infectious Diseases
3.09.2024
In all1 countries around the world, women live longer than men [1,2]. There is well-established evidence of a gender mortality gap driven by a range of environmental, genetic, and cultural factors [3]. The persistence of higher mortality for men than women has been documented with data typically drawn principally from high-income countries [4]. But these patterns have also been shown in low-income regions of the world [5].
BMC Infectious Diseases
3.09.2024
…g real-world data. . . . Methods. We analyzed the electronic medical records of adult patients admitted to Busan Medical Center after confirming coronavirus disease 2019 (COVID-19) from February 1, 2020, to June 30, 2022. Patients with mild-to-moderate COVID-19 who were at a high risk of disease progression were selected as study subjects, and the time period was classified according to the variants as ancestral strain, Del…
BMC Infectious Diseases
3.09.2024
. Abstract. . Background. To mitigate hospital-acquired transmission of coronavirus disease 2019 (COVID-19), various prevention and control measures have been strictly implemented in medical institutions. These stringent measures can potentially reduce the incidence of hospital-acquired respiratory infections. This study aimed to assess if there were changes in the prevalence of hospital-acquired respiratory infections durin…
BMC Infectious Diseases
3.09.2024
. Abstract. . Background. After a 920-day hiatus, COVID-19 resurged in the Tibet Autonomous Region of China in August 2022. This study compares the characteristics of COVID-19 between high-altitude residents and newcomers, as well as between newcomers and lowlanders. . . . Methods. This multi-center cohort study conducted at the Third People…
BMC Infectious Diseases
3.09.2024
. Abstract. . Background. Studying the characteristics of hospitalized Coronavirus Disease 2019 (COVID-19) patients is vital for understanding the disease and preparing for future outbreaks. The aim of this study was to analyze and describe the clinical profiles and factors associated with mortality among COVID-19 patients admitted to Jimma Medical Center COVID-19 Treatment Center (JMC CTC) in Ethiopia. . …
Lancet Infectious Diseases
3.09.2024
…onset of the pandemic, Glenda Gray, Lead Co-Investigator at Sisonke and President of the South African Medical Research Council, did something that she had not done in years: she stopped wearing her watch. March, 2020, marked the beginning of a societal standstill as restrictions to curb the spread of COVID-19 came into effect in South Africa and across the world. For Gray, time had paused. “Time will begin again when the pandemic is over”, she reflects, quoting Bob Dylan: The times they are a-changing.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Medscape Infectious Diseases
11.09.2024
Pfizer and Moderna mRNA vaccines are updated to better match currently circulating COVID strains, while the Novavax adjuvant will target the JN.1 variant — a predecessor of KP.2. . Medscape Medical News
Eurosurveillance latest updates
30.08.2024
. Background. COVID-19 remains a major infectious disease with substantial implications for individual and public health including the risk of a post-infection syndrome, long COVID. The continuous changes in dominant variants of SARS-CoV-2 necessitate a careful study of the effect of preventative strategies. . . Aim. We aimed to estimate the effectiveness of post-vaccination, post-infection and hybrid immunity against severe cases requiring oxygen support caused by infections with SARS-CoV-2 variants BA1…
Medscape Infectious Diseases
28.08.2024
The program's end will leave the Canadian province without a valuable tool for monitoring infectious disease. . Medscape Medical News
Medscape Infectious Diseases
23.08.2024
A large study shows higher rates of depression and mental illness up to a year after COVID-19, especially severe cases of the infection, in unvaccinated adults. . Medscape Medical News
Eurosurveillance latest updates
23.08.2024
. Background. Vaccine uptake differs between social groups. Mobile vaccination units (MV-units) were deployed in the Netherlands by municipal health services in neighbourhoods with low uptake of COVID-19 vaccines. . . Aim. We aimed to evaluate the impact of MV-units on vaccine uptake in neighbourhoods with low vaccine uptake. . . Methods. We used the Dutch national-level registry of COVID-19 vaccinations (CIMS) and MV-unit deployment registrations containing observations in 253 neighbourhoods where MV…
Eurosurveillance latest updates
9.08.2024
. Background. A new respiratory virus surveillance platform, based on nationwide hospital laboratory data, was established in Israel during the COVID-19 pandemic. . . Aim. We aimed to evaluate the performance of this platform with respect to the detection of influenza and respiratory syncytial virus (RSV) from week 36 in 2020 to week 15 in 2023, and how it fits with the World Health Organization (WHO) mosaic surveillance framework. . . Methods. Data of respiratory samples from hospitalised patients se…
Statens Serum Institut
8.08.2024
Ny undersøgelse fra WHO/Europa bekræfter den livsreddende effekt af covid-19-vacciner. Statens Serum Institut (SSI) har bidraget til undersøgelsen, som er relevant i en tid med flere årlige smittebølger.
Eurosurveillance latest updates
20.07.2024
. Background. The COVID-19 pandemic and the emergence of Candida auris have changed the epidemiological landscape of candidaemia worldwide. . . Aim. We compared the epidemiological trends of candidaemia in a Greek tertiary academic hospital before (2009–2018) and during the early COVID-19 (2020–2021) and late COVID-19/early post-pandemic (2022–2023) era. . . Methods. Incidence rates, species distribution, antifungal susceptibility profile and antifungal consumption were recorded, and one-way ANO…
Eurosurveillance latest updates
12.07.2024
. Background. As Ireland prepared for an autumn 2023 COVID-19 vaccination booster campaign, there was concern that vaccine fatigue would affect uptake, which has been abating. . . Aim. This study aimed to quantify the direct impact of the COVID-19 vaccination programme in Ireland on averted COVID-19-related outcomes including symptomatic presentations to primary care/community testing centres, emergency department (ED) presentations, hospitalisations, intensive care unit (ICU) admissions and deaths, in i…
Eurosurveillance latest updates
22.06.2024
. Background. Non-severe adverse events (AE) including pain at injection site or fever are common after COVID-19 vaccination. . . Aim. To describe determinants of AE after COVID-19 vaccination and investigate the association between AE and pre- and post-vaccination antibody concentrations. . . Methods. Participants of an ongoing prospective cohort study (VASCO) completed a questionnaire on AE within 2 months after vaccination and provided 6 monthly serum samples during May 2021–November 2022. Logist…
Eurosurveillance latest updates
17.05.2024
.
Medscape Infectious Diseases
16.05.2024
CDC experts share what clinicians should know about COVID-19 prevention in immunocompromised patients. . CDC Expert Commentary
Morbidity and Mortality Weekly Report (MMWR)
26.04.2024
This report describes a recommendation from the Advisory Committee on Immunization Practices that all people ages ≥65 years and older receive one additional dose of any updated (2023-2024 Formula) COVID-19 vaccine.
Morbidity and Mortality Weekly Report (MMWR)
19.04.2024
This report describes COVID-19 rates, hospitalizations, and vaccination coverage among nursing home residents.
Morbidity and Mortality Weekly Report (MMWR)
19.04.2024
This report describes the duration of protection provided by the original monovalent COVID-19 vaccines.
ECDC COVID-19 updates
17.04.2024
This report collects all COVID-19 long-term care facilities (LTCF) data reported to ECDC from 2021 and concludes the EU/EEA LTCF COVID-19 specific surveillance data collection from 2021-2023.
Eurosurveillance latest updates
12.04.2024
…ropean Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023–6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI: 91.7–98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season. .
Morbidity and Mortality Weekly Report (MMWR)
12.04.2024
This report describes a review of Oregon death certificate data to assess whether young people in Oregon might be dying after receiving a COVID-19 vaccine.
Morbidity and Mortality Weekly Report (MMWR)
12.04.2024
This report describes COVID-19 vaccination coverage in the World Health Organization African Region during 2021-2023.
ECDC COVID-19 updates
8.04.2024
This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses (compared to complete primary vaccination with no booster) against hospitalisation due to COVID-19 and COVID-19-related death in resident populations ≥50 years of age living in the community.